Meeting
2014 Genitourinary Cancers Symposium
Preclinical activity of the heat shock protein 90 inhibitor ganetespib in clear cell renal cell carcinoma.
Authors
Mansi Parasramka
Mayo Clinic, Jacksonville, FL
Mansi Parasramka , David A. Proia , Richard Wayne Joseph
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Renal Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 478)
DOI
10.1200/jco.2014.32.4_suppl.478
Abstract #
478
Poster Bd #
F11
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Preclinical evaluation of teleglenastat (CB-839) in prostate cancer.
First Author: Elaine T. Lam
Poster
2023 ASCO Genitourinary Cancers Symposium
Therapeutic potential of plant-derived nanovesicles for neuroendocrine prostate cancer.
First Author: Sharanjot Saini
Poster
2022 ASCO Genitourinary Cancers Symposium
Effectiveness of first-line therapy in patients with advanced non-clear renal cell carcinoma (nccRCC).
First Author: Sophie Laramee
Poster
2014 ASCO Annual Meeting
Essential experimental steps and estimates of renal carcinoma initiating cells.
First Author: Craig Gedye